🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
25.37
-1.14 (-4.30%)
At close: Nov 20, 2026, 4:00 PM EST
25.42
+0.05 (0.20%)
After-hours: Nov 20, 2026, 7:30 PM EST

Alto Neuroscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
-----0.21
Revenue Growth
------
Gross Profit
-----0.21
Selling, General & Admin
27.9920.7521.617.525.53.9
Research & Development
72.5645.624730.2923.698.37
Operating Expenses
100.5566.3668.6137.8129.1912.27
Operating Income
-100.55-66.36-68.61-37.81-29.19-12.06
Interest Expense
-2.07-2.47-1.38-1.37--
Interest & Investment Income
7.836.68.852.350.110
Other Non Operating Income (Expenses)
-0.39-0.33-0.30.531.372.87
EBT Excluding Unusual Items
-95.18-62.56-61.43-36.31-27.71-9.19
Other Unusual Items
--0.68----
Pretax Income
-95.18-63.24-61.43-36.31-27.71-9.19
Net Income
-95.18-63.24-61.43-36.31-27.71-9.19
Net Income to Common
-95.18-63.24-61.43-36.31-27.71-9.19
Net Income Growth
------
Shares Outstanding (Basic)
402925432
Shares Outstanding (Diluted)
402925432
Shares Change
49.20%17.27%559.39%8.27%42.78%-
EPS (Basic)
-2.36-2.19-2.50-9.73-8.04-3.81
EPS (Diluted)
-2.36-2.19-2.50-9.73-8.04-3.81
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-79.68-51.79-49.5-33.92-21.13-9.94
Free Cash Flow Per Share
-1.98-1.79-2.01-9.09-6.13-4.12
Gross Margin
-----100.00%
Operating Margin
------5740.95%
Profit Margin
------4374.76%
Free Cash Flow Margin
------4734.29%
EBITDA
-99.84-65.7-68.11-37.44-28.85-11.91
D&A For EBITDA
0.710.660.50.370.340.15
EBIT
-100.55-66.36-68.61-37.81-29.19-12.06
SEC Filings: 10-K · 10-Q